Huntington's disease (HD) is a progressive neurodegenerative disease that affects the striatum and 21 cerebral cortex. It is caused by a dominant CAG trinucleotide expansion in exon 1 of the HTT gene. 22
HD--positive individuals exhibit increased systemic inflammation, marked by elevated interleukin 6 and 48 other cytokines, that begins years before clinical onset (Björkqvist et al., 2008) . However, the 49 relationship between peripheral and brain inflammation in HD is poorly understood. Further, the extent 50 to which inflammation in HD results from intrinsic effect of mHtt versus altered responses to 51 environmental stimuli is unclear. 52
Monocytic cells in Huntington's disease 53
Microglial and monocytes are innate immune cells that may contribute to HD pathogenesis. 54
Microglia are monocyte--like CNS--resident cells and express many of the same surface receptors and 55 markers as peripheral monocytes (Greter et al., 2015) . Peripheral monocytes are cellular precursors of 56 tissue--resident macrophages, dendritic cells, monocyte--derived suppressor cells and infiltrating 57 microglial--like cells in the CNS (Greter et al., 2015) . Both microglial cells and monocytes can be activated 58 by immune mediators as well as directly by microbial molecules. 59 Mutant huntingtin is expressed in both microglia and monocytes in HD patients (Weiss et al., 60 2012 ). In the absence of external inflammatory stimulation, mHtt promotes cell--autonomous activation 61 of primary microglial cells (Crotti et al., 2014) . Immune cells from pre--manifest HD patients and mouse 62 models demonstrate a pro--inflammatory phenotype as illustrated by increased levels of several 63 cytokines in blood, including interleukin--6 (IL--6) (Crotti et al., , Björkqvist et al., 2008 . Mutant 64 huntingtin expression in human monocytes is associated with increased production of cytokines 65 interleukin--6 (IL--6), IL--1β, and TNF--α (Träger et al., 2014) . IInterleukin--6 induces microglial proliferation 66 and is associated with increased microglia proliferation in response to mHtt--expressing neurons (Kraft et 67 al., 2012) . Furthermore, monocytes isolated from HD patients and mice had reduced chemotactic 68 responses to ATP and complement protein C5a further demonstrating that mHtt exerts a modifying 69 effect on these cells (Kwan et al., 2012) . Together, these data indicate that HD monocytes and microglia 70 have changes in basal activation state and that mHtt may alter how monocyte--derived cells respond to 71 innate immune stimuli and/or sensitivity to cytokine and chemokine stimulation. 72
Macrophages can be polarized in their response to be either "M1" or "M2" cells (Mills et al., 73 2000) . In HD, expression of CCR2 and production of the pro--inflammatory cytokine IL--12 are used to 74 identify M1 macrophages while CX3CR1 expression and immunosuppressive IL--10 production are used 75 to identify M2 macrophages (Di Pardo et al., 2013) . Interestingly, HD patient monocytes are initially 76 more M1 polarized as evidenced by increased percentages of CCR2+ and IL--12+ macrophages before 77 disease onset, with a transition to M2 macrophages that express CX3CR1 and IL--10 later in the disease 78 course (Di Pardo et al., 2013). The M1--M2 polarization is partially mediated by nuclear factor kappa--79 light--chain--enhancer of activated B--cells (NF--κB) (Tugal et al., 2013) . Activation of the NF--κB p65 subunit 80 is critical for development of M1--associated functions in macrophages and NF--κB p65 is increased in HD 81 patients before clinical (Di Pardo et al., 2013). Thus, one putative mechanism of aberrant pro--82 inflammatory responses observed during HD is the dysregulation of NF--κB activation in monocytes. The 83 switch of monocytes to acquire a more M2--like phenotype later in the disease course could indicate a 84 compensatory change to counteract the sustained NF--κB activation and M1--associated inflammatory 85 state early in HD. 86
Compared to monocytes, less is known about how mHtt impacts the inflammatory status and 87 the responsiveness of microglial cells to immune stimulation. Mouse models of HD demonstrate that 88 mHtt can modify microglial responses. Lipopolysaccharide (LPS) treatment of YAC128 HD mice, which 89 express full--length mHtt, have increased microglial cell activation compared to wild--type litter--mates 90 (Franciosi et al., 2012) . N171--82Q HD mice have increased brain indoleamine--2,3--dioxygenase, a 91 microglial enzyme activated by inflammation, and an altered response to the protozoan Toxoplasma 92 gondii (Donley et al., 2016). Therefore, based on previous studies, it is our perspective that mHtt 93 presence is sufficient to activate monocytes/microglia and alter both the inflammatory profile and 94 responses to extrinsic immune stimulation. 95 These findings support the possibility that if mHtt increases activation of NF--κB then synergy 117 with other pathways, such as STAT signaling, could promote inflammation in HD. Evidence suggests that 118 STAT--dependent cytokine signaling may synergize with NF--κB--activating PRR signaling to produce a 119 hyper--responsive state in HD monocytes and microglia treated with LPS (NF--κB--activating) and IFN--γ 120 (STAT--activating) (Björkqvist et al., 2008). However, it is unknown which signaling mechanism(s), PRR or 121 JAK/STAT, are altered by mHtt and whether mHtt differentially impacts these pathways. Therefore, here 122 we tested whether mHtt expressing microglial cells have altered responses to LPS to model PRR 123 stimulation, and also to IL--6 stimulation to model STAT--mediated immune stimulation. 124
NF--κB pathway activation in Huntington's disease

Mutant huntingtin expression alters microglial responses to immune stimuli 125
The mouse microglial cell line EOC--20 (American Type Culture Company, CTRL--2469) was utilized 126 as they have previously been used to study responses to inflammatory stimulus (Hensley et al., 2003, 127 Mencel et al., 2013, Guadagno et al., 2013 . Cells were cultured at 37°C and 5% CO 2 128 in high glucose DMEM media supplemented with 20% v/v LADMAC--conditioned media according to 129 ATCC guidelines. LADMAC cells are bone marrow--derived cells that produce high amounts of colony 130 stimulating factor--1 needed to support EOC--20 cell growth . Conditioned media was 131 collected and frozen at --20°C until use. Wild--type (N181--18Q) or mHtt (N171--82Q) protein, or eGFP were 132 expressed in EOC--20 cells using independent lentiviruses that use the phosphoglycerate kinase 133 promoter. Huntingtin constructs expressed the first 3 introns of human HTT, including the CAG tract in 134 exon 1. For each of the three viruses, a four--plasmid system was used; plasmids were transfected into 135 HEK293T cells, virus was harvested from the media, quantified, and stored as previously described (Fox 136 et al., 2015) . 137
We evaluated viral transduction efficiency using eGFP--encoding virus. We identified 77.8% ± 2.5 138 (means ± SE, n=4) GFP--positive cells 24 hours post transduction ( Fig. 1A) . We further verified N171--139 18/82Q expression using the MAB5492 (EMD Millipore) (Figs. 1B--C). Inclusions were not observed. 140
Because the antibody also identifies endogenous murine huntingtin we quantified total cellular 141 fluorescence on a per--cell basis in mock transduced and N171 huntingtin expressing cells. N171--18/82Q 142 expression resulted in a greater than 2--fold increase in expression over levels attributed to endogenous 143 huntingtin protein ( Fig. 1D) . There was no effect of N171--18/82Q expression on cell viability compared 144 to GFP as measured using a lactate dehydrogenase release assay (Fig. 1E) . The microglial culture model 145 therefore provides a way to assess the effects of mHtt on intrinsic responses to inflammatory stimuli. 146
Effects of wild--type huntingtin and mHtt on the microglial cells was assessed by measuring 147 responses to E. coli LPS (Sigma) and interleukin--6 (Biolegend). We measured nitrite, iNOS and NF--κB 148 levels in response to these; additionally we measured IL--6 production after LPS stimulation. Nitrite is an 149 oxidative product of NO that is further oxidized in medium to nitrate. Nitrates were reduced to nitrite 150 using Aspergillus nitrate reductase and the Griess test was used to quantify nitrite (Guevara et al., 1998 , 151 Gilliam et al., 1993 . Total nitrite/nitrate (hereafter called nitrite) is a surrogate for iNOS activity. 152
Standards were made using sodium nitrite in cell culture media. IL--6 was quantified using an ELISA 153 according to manufacturer's guidelines (Biolegend). Relative iNOS was quantified using an ELISA 154 (MyBioSource) (Mendonca et al., 2017) . Activation of NF--κB was quantified using an ELISA for total and 155 phosphorylated p65 subunit levels (Thermo Fisher) (Roth--Walter et al., 2014). The ratio of 156 phosphorylated to total NFκB p65 is presented with increasing ratio indicative of activation. As expected 157 both GFP and N171--18Q expressing cells demonstrated significantly increased IL--6 and nitrite levels in 158 response to LPS. However, N171--82Q expressing cells lacked a response to LPS ( Figs. 2A--B) . Consistent 159 with decreased nitrite levels following LPS stimulation, iNOS levels in N171--82Q cells did not increase 160 following LPS treatment (Fig. 2C) . Since LPS activates NF--κB which then upregulates expression of IL--6 161 and iNOS we quantified NF--κB activation in our cells with and without LPS stimulation. Baseline NF--κB 162 activation measured by p65 subunit phosphorylation was increased in N171--82Q expressing cells 163 compared to GFP and N171--18Q expressing cells (Fig. 2D) . Low dose LPS increased NF--κB in GFP and 164 N171--18Q expressing cells only while high does LPS increased NF--κB in all groups compared to no LPS 165 controls (Fig. 2D) . 166 We then tested the effect of STAT pathway--inducing IL--6 on iNOS and NF--κB activation. IL--6 did 167 not have a significant effect in GFP and N171--18Q groups; however, N171--82Q cells demonstrated 168 significantly increased nitrite production and iNOS levels ( Figs. 2E--F) . N171--82Q expressing cells also 169 demonstrated increased NF--κB activation after IL--6 stimulation ( Fig. 2G) and had a greater level of NF--170 κB activation compared to low dose LPS (Fig. 2D) . These results indicate that mHtt sensitizes these cells 171 to IL--6 stimulation, an effect opposite to that of LPS (see model Fig. 2H) . and IL--6--mediated stimulation. Not only did mHtt alter microglial immune responses, but the direction 179 of the response depended on the nature of stimulation (Fig. 2) . effects on these responses (Fig. 2H) . We observed that mHtt rendered the microglial cells 192 hyporesponsive to low--dose LPS, but hypersensitive to IL--6, a cytokine that activates STAT pathways 193 ( Figs. 2E--H) . STAT3 signaling downstream of IL--6 can synergize with NF--κB to promote inflammation 194 (Grivennikov and Karin, 2010, Yang et al., 2007) . Therefore, one possibility is that mHtt, despite reducing 195 PRR signaling downstream of LPS stimulation, could promote synergy of NF--κB (from a PRR agonist) and 196 STAT transcription factors (from cytokine signaling) and enhance immune activation. Our data suggests 197 the possibility of a novel mechanism underlying HD--associated neuroinflammation driven by interaction 198 of NF--κB and STAT signaling pathways and/or the differential effect of mHtt on these pathways. 199
The findings also suggest a possible mechanism where IL--6 downstream of LPS stimulation is 200 necessary in microglial cells to drive iNOS activity and NO production. When mHtt--expressing cells are 201 stimulated with IL--6, NF--κB activation and nitrite are greatly increased. Given these data, we think that 202 the IL--6 requirement for iNOS activity in microglia is not a complete explanation of our results. Therefore 203 our perspective, taking into consideration previously published studies, is that mHtt has disparate 204 effects on PRR signaling and STAT signaling pathways that differentially impacts sensitivity of cells to 205 extrinsic stimuli which impacts microglial activation. Cell culture studies may not replicate all aspects of 206 endogenous microglia, therefore additional studies are needed to determine if similar effects of mHtt on 207 microglia occur in other microglial culture models and in vivo. responses in mHtt expressing microglial cells. These finding suggest that mHtt may also alter responses 216 to other immune molecules, microbial antigens, or neurotropic pathogens. If these mechanisms apply to 217 human HD then these could contribute significantly to modifying age of onset or progression by altering 218 systemic and brain inflammatory pathways. More work is clearly needed to fully understand the 219 mechanisms underlying altered immune responses in HD cells. However, the findings contribute to 220 understanding mechanisms of mHtt--induced neuroinflammation and neurodegeneration as well as the 221 variability in human HD. The Wyoming INBRE 2 award (NCRR--P20RR016474/ NIGMS--P20GM103432) provided an undergraduate 226 research fellowship to RN and a graduate student fellowship to DWD. We thank Dr. Donald Jarvis for use 227 of laboratory equipment. 228
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